Choosing the right one depends on medical guidance and specific injection needs
Weight Loss: Over 6 months, patients on exenatide lost on average ~45 kg (811 lbs), whereas those on comparator therapies often lost little or even gained weight ( [6] ) ( [61] )
Heres why: The 12-week study was done on 60 people, divided into three groups
It acts as a cofactor for essential enzymes involved in tissue repair, antioxidant defense, and even gene expression
In response, leading pharmas have announced massive capacity expansions: Novo Nordisk plans a $4.1 billion manufacturing facility in North Carolina ( [5] ) (opening ~2029), and Lilly has committed over $15 billion for new plants in Indiana, Wisconsin, Pennsylvania, and Alabama ( [6] ) ( [7] ) ( [8] ) ( [9] )